A novel Nav1.5-dependent feedback mechanism driving glycolytic acidification in breast cancer metastasis

Theresa K. Leslie, Aurelien Tripp, Andrew D. James, Scott P. Fraser, Michaela Nelson, Nattanan Sajjaboontawee, Alina L. Capatina, Michael Toss, Wakkas Fadhil, Samantha C. Salvage, Mar Arias Garcia, Melina Beykou, Emad Rakha, Valerie Speirs, Chris Bakal, George Poulogiannis, Mustafa B.A. Djamgoz, Antony P. Jackson, Hugh R. Matthews, Christopher L.H. HuangAndrew N. Holding, Sangeeta Chawla, William J. Brackenbury* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
6 Downloads (Pure)

Abstract

Solid tumours have abnormally high intracellular [Na+]. The activity of various Na+ channels may underlie this Na+ accumulation. Voltage-gated Na+ channels (VGSCs) have been shown to be functionally active in cancer cell lines, where they promote invasion. However, the mechanisms involved, and clinical relevance, are incompletely understood. Here, we show that protein expression of the Nav1.5 VGSC subtype strongly correlates with increased metastasis and shortened cancer-specific survival in breast cancer patients. In addition, VGSCs are functionally active in patient-derived breast tumour cells, cell lines, and cancer-associated fibroblasts. Knockdown of Nav1.5 in a mouse model of breast cancer suppresses expression of invasion-regulating genes. Nav1.5 activity increases ATP demand and glycolysis in breast cancer cells, likely by upregulating activity of the Na+/K+ ATPase, thus promoting H+ production and extracellular acidification. The pH of murine xenograft tumours is lower at the periphery than in the core, in regions of higher proliferation and lower apoptosis. In turn, acidic extracellular pH elevates persistent Na+ influx through Nav1.5 into breast cancer cells. Together, these findings show positive feedback between extracellular acidification and the movement of Na+ into cancer cells which can facilitate invasion. These results highlight the clinical significance of Nav1.5 activity as a potentiator of breast cancer metastasis and provide further evidence supporting the use of VGSC inhibitors in cancer treatment.

Original languageEnglish
Pages (from-to)2578–2594
Number of pages17
JournalOncogene
Volume43
Early online date25 Jul 2024
DOIs
Publication statusPublished - 16 Aug 2024

Bibliographical note

The authors wish to acknowledge the roles of the Breast Cancer Now Tissue Bank in
collecting and making available the samples and data, and the patients who have
generously donated their tissues and shared their data to be used in the generation
of this publication. The authors also thank Prof. Miles Whittington (Hull-York Medical
School, UK), Dr. John Davey and Dr. Katherine Newling (Technology Facility, University of York, UK), and Prof. Lýdia Vargová (Charles University, Czechia) for
providing invaluable advice. For the purpose of open access, a Creative Commons
Attribution (CC BY) licence is applied to any author accepted manuscript version
arising from this submission.

Data Availability Statement

DATA AVAILABILITY
The RNA-seq data are deposited in the GEO database, accession number GSE228621.
CODE AVAILABILITY
The code used to analyse the data is available from https://github.com/
andrewholding/RNASeq-SCN5A

Fingerprint

Dive into the research topics of 'A novel Nav1.5-dependent feedback mechanism driving glycolytic acidification in breast cancer metastasis'. Together they form a unique fingerprint.

Cite this